Locus coeruleus lesions in the rat enhance the antinociceptive potency of centrally administered clonidine but not morphine

M. H. Ossipov, Tapan Kumar Chatterjee, G. F. Gebhart

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The nucleus locus coeruleus (LC) has been implicated in the descending inhibition of spinal nociceptive dorsal horn neurons, spinal nociceptive reflexes and in the antinociception produced by morphine. To further explore the involvement of the LC in antinociception, bilateral electrolytic lesions in the LC were made in adult male Sprague-Dawley rats. Lesions in the LC did not alter the antinociception produced by morphine (2.5 and 5 μg) administered in the periaqueductal gray in either the tail-flick (TF) or hot-plate (HP) tests when tested 7 and 14 days after the lesions. Baseline nociceptive thresholds in the TF and HP tests likewise were not affected at 7 or 14 days post-lesion. In contrast, the antinociceptive potency of clonidine administered intrathecally on day 13 post-lesion was enhanced significantly in the TF test; the antinociceptive ED50 of the LC lesion group was 0.52 μg whereas that of the sham lesion group was 2.29 μg. The antinociceptive potency of clonidine administered systemically (750 and 500 μg/kg, s.c.) was also enhanced in the LC lesion group in the TF but not the HP test. Norepinephrine (NE) in the lumbar spinal cord was correlated negatively and significantly with the extent of destruction of the LC. The lumbar spinal content of NE was reduced maximally at 12 days post-lesion (56% of control). The binding of [3H]clonidine in the lumbar spinal cord was slightly greater in the LC lesion than sham lesion group; the Bmax values were 42.4 fmol/mg protein and 35.5 fmol/mg protein for the LC lesion and sham lesion groups, respectively. It is suggested that the LC participates in the descending inhibition of spinal nociceptive transmission and that this inhibition may be mediated in the spinal cord by alpha-2 adrenoceptors located postsynaptically with respect to the NE terminals of the spinopetal LC efferents.

Original languageEnglish (US)
Pages (from-to)320-330
Number of pages11
JournalBrain Research
Volume341
Issue number2
DOIs
StatePublished - Aug 26 1985

Fingerprint

Locus Coeruleus
Clonidine
Morphine
Spinal Cord
Tail
Norepinephrine
Posterior Horn Cells
Periaqueductal Gray
Nociceptors
Adrenergic Receptors
Sprague Dawley Rats
Reflex
Proteins

Keywords

  • antinociception
  • clonidine
  • locus coeruleus
  • morphine
  • supersensitivity

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Locus coeruleus lesions in the rat enhance the antinociceptive potency of centrally administered clonidine but not morphine. / Ossipov, M. H.; Chatterjee, Tapan Kumar; Gebhart, G. F.

In: Brain Research, Vol. 341, No. 2, 26.08.1985, p. 320-330.

Research output: Contribution to journalArticle

Ossipov, M. H. ; Chatterjee, Tapan Kumar ; Gebhart, G. F. / Locus coeruleus lesions in the rat enhance the antinociceptive potency of centrally administered clonidine but not morphine. In: Brain Research. 1985 ; Vol. 341, No. 2. pp. 320-330.
@article{7fa82258365247448ab640550d1ac439,
title = "Locus coeruleus lesions in the rat enhance the antinociceptive potency of centrally administered clonidine but not morphine",
abstract = "The nucleus locus coeruleus (LC) has been implicated in the descending inhibition of spinal nociceptive dorsal horn neurons, spinal nociceptive reflexes and in the antinociception produced by morphine. To further explore the involvement of the LC in antinociception, bilateral electrolytic lesions in the LC were made in adult male Sprague-Dawley rats. Lesions in the LC did not alter the antinociception produced by morphine (2.5 and 5 μg) administered in the periaqueductal gray in either the tail-flick (TF) or hot-plate (HP) tests when tested 7 and 14 days after the lesions. Baseline nociceptive thresholds in the TF and HP tests likewise were not affected at 7 or 14 days post-lesion. In contrast, the antinociceptive potency of clonidine administered intrathecally on day 13 post-lesion was enhanced significantly in the TF test; the antinociceptive ED50 of the LC lesion group was 0.52 μg whereas that of the sham lesion group was 2.29 μg. The antinociceptive potency of clonidine administered systemically (750 and 500 μg/kg, s.c.) was also enhanced in the LC lesion group in the TF but not the HP test. Norepinephrine (NE) in the lumbar spinal cord was correlated negatively and significantly with the extent of destruction of the LC. The lumbar spinal content of NE was reduced maximally at 12 days post-lesion (56{\%} of control). The binding of [3H]clonidine in the lumbar spinal cord was slightly greater in the LC lesion than sham lesion group; the Bmax values were 42.4 fmol/mg protein and 35.5 fmol/mg protein for the LC lesion and sham lesion groups, respectively. It is suggested that the LC participates in the descending inhibition of spinal nociceptive transmission and that this inhibition may be mediated in the spinal cord by alpha-2 adrenoceptors located postsynaptically with respect to the NE terminals of the spinopetal LC efferents.",
keywords = "antinociception, clonidine, locus coeruleus, morphine, supersensitivity",
author = "Ossipov, {M. H.} and Chatterjee, {Tapan Kumar} and Gebhart, {G. F.}",
year = "1985",
month = "8",
day = "26",
doi = "10.1016/0006-8993(85)91071-6",
language = "English (US)",
volume = "341",
pages = "320--330",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Locus coeruleus lesions in the rat enhance the antinociceptive potency of centrally administered clonidine but not morphine

AU - Ossipov, M. H.

AU - Chatterjee, Tapan Kumar

AU - Gebhart, G. F.

PY - 1985/8/26

Y1 - 1985/8/26

N2 - The nucleus locus coeruleus (LC) has been implicated in the descending inhibition of spinal nociceptive dorsal horn neurons, spinal nociceptive reflexes and in the antinociception produced by morphine. To further explore the involvement of the LC in antinociception, bilateral electrolytic lesions in the LC were made in adult male Sprague-Dawley rats. Lesions in the LC did not alter the antinociception produced by morphine (2.5 and 5 μg) administered in the periaqueductal gray in either the tail-flick (TF) or hot-plate (HP) tests when tested 7 and 14 days after the lesions. Baseline nociceptive thresholds in the TF and HP tests likewise were not affected at 7 or 14 days post-lesion. In contrast, the antinociceptive potency of clonidine administered intrathecally on day 13 post-lesion was enhanced significantly in the TF test; the antinociceptive ED50 of the LC lesion group was 0.52 μg whereas that of the sham lesion group was 2.29 μg. The antinociceptive potency of clonidine administered systemically (750 and 500 μg/kg, s.c.) was also enhanced in the LC lesion group in the TF but not the HP test. Norepinephrine (NE) in the lumbar spinal cord was correlated negatively and significantly with the extent of destruction of the LC. The lumbar spinal content of NE was reduced maximally at 12 days post-lesion (56% of control). The binding of [3H]clonidine in the lumbar spinal cord was slightly greater in the LC lesion than sham lesion group; the Bmax values were 42.4 fmol/mg protein and 35.5 fmol/mg protein for the LC lesion and sham lesion groups, respectively. It is suggested that the LC participates in the descending inhibition of spinal nociceptive transmission and that this inhibition may be mediated in the spinal cord by alpha-2 adrenoceptors located postsynaptically with respect to the NE terminals of the spinopetal LC efferents.

AB - The nucleus locus coeruleus (LC) has been implicated in the descending inhibition of spinal nociceptive dorsal horn neurons, spinal nociceptive reflexes and in the antinociception produced by morphine. To further explore the involvement of the LC in antinociception, bilateral electrolytic lesions in the LC were made in adult male Sprague-Dawley rats. Lesions in the LC did not alter the antinociception produced by morphine (2.5 and 5 μg) administered in the periaqueductal gray in either the tail-flick (TF) or hot-plate (HP) tests when tested 7 and 14 days after the lesions. Baseline nociceptive thresholds in the TF and HP tests likewise were not affected at 7 or 14 days post-lesion. In contrast, the antinociceptive potency of clonidine administered intrathecally on day 13 post-lesion was enhanced significantly in the TF test; the antinociceptive ED50 of the LC lesion group was 0.52 μg whereas that of the sham lesion group was 2.29 μg. The antinociceptive potency of clonidine administered systemically (750 and 500 μg/kg, s.c.) was also enhanced in the LC lesion group in the TF but not the HP test. Norepinephrine (NE) in the lumbar spinal cord was correlated negatively and significantly with the extent of destruction of the LC. The lumbar spinal content of NE was reduced maximally at 12 days post-lesion (56% of control). The binding of [3H]clonidine in the lumbar spinal cord was slightly greater in the LC lesion than sham lesion group; the Bmax values were 42.4 fmol/mg protein and 35.5 fmol/mg protein for the LC lesion and sham lesion groups, respectively. It is suggested that the LC participates in the descending inhibition of spinal nociceptive transmission and that this inhibition may be mediated in the spinal cord by alpha-2 adrenoceptors located postsynaptically with respect to the NE terminals of the spinopetal LC efferents.

KW - antinociception

KW - clonidine

KW - locus coeruleus

KW - morphine

KW - supersensitivity

UR - http://www.scopus.com/inward/record.url?scp=0022363730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022363730&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(85)91071-6

DO - 10.1016/0006-8993(85)91071-6

M3 - Article

C2 - 4041798

AN - SCOPUS:0022363730

VL - 341

SP - 320

EP - 330

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -